Related Experiment Video
Updated: Dec 26, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Does Atrial Fibrillation Increase the Risk of Developing End-stage Renal Disease in Patients with Chronic Kidney
Kulachanya Suwanwongse1, Nehad Shabarek1
1Internal Medicine, Lincoln Medical Center, New York City, USA.
Insights
Atrial fibrillation (AF) significantly increases the risk of end-stage renal disease (ESRD) in patients with chronic kidney disease (CKD). This finding highlights AF as an independent risk factor for CKD progression to ESRD.
Area of Science:
- Nephrology
- Cardiology
- Epidemiology
Background:
- Atrial fibrillation (AF) is linked to increased risks of stroke, heart failure, and myocardial infarction.
- The effect of AF on chronic kidney disease (CKD) progression remains unclear.
- End-stage renal disease (ESRD) represents the final stage of CKD.
Purpose of the Study:
- To determine if AF is associated with an increased risk of developing ESRD in patients with CKD.
- To investigate the impact of AF on the progression of CKD.
Main Methods:
- A systematic search of the MEDLINE database was conducted on January 31, 2019.
- Included were human, English-language studies evaluating the association between AF and CKD progression to ESRD.
- One prospective cohort study involving 3,091 CKD patients with a mean follow-up of 5.9 years was analyzed.
Main Results:
- The study identified 172 CKD patients who developed AF, with 43 progressing to ESRD.
- Among 2,919 CKD patients without incident AF, 581 progressed to ESRD.
- The ESRD incidence rate was 11.8 per 100 person-years in patients with AF versus 3.4 per 100 person-years in those without AF.
Conclusions:
- Atrial fibrillation is an independent risk factor for the development of ESRD in patients with CKD.
- Further research is required to substantiate these findings and explore underlying mechanisms.
Abstract:
Patients with atrial fibrillation (AF) have elevated risks of developing stroke, heart failure, and myocardial infarction. However, the impact of AF on the progression of chronic kidney disease (CKD) is uncertain. Our review objective is to investigate whether AF increases the risk of developing end-stage renal disease (ESRD) in patients with CKD. On 31 January 2019, a systemic search was performed on the MEDLINE database using the predefined search criteria. Limits included human participants and English-language publications. Studies that evaluated an association of AF and the risk of CKD progression to ESRD were selected. A total of 751 articles were identified. One prospective cohort study was included after screening abstracts from overall retrieved studies based on our inclusion/exclusion criteria, with a total of 3,091 CKD patients and a mean follow-up of 5.9 years. A total of 172 CKD patients developed AF, of which 43 patients later developed ESRD. Of 2,919 CKD patients with no incident AF, 581 patients progressed to ESRD. The rate of ESRD after the development of AF was 11.8/100 person-years compared with 3.4/100 person-years in CKD patients without AF. In conclusion, AF is an independent risk factor for developing ESRD in CKD patients, but more evidence is needed to support this result.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care

